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Objective:The TransAtlantic Inter-Society Consensus (TASC) document did not define the best treatment for moderately
severe iliac artery lesions, ie, TASC type B and type C iliac lesions, because of insufficient solid evidence to make firm
recommendations. The purpose of this study was to evaluate the influence of risk factors on outcome of iliac stenting and
operative procedures used to treat TASC type B and type C lesions.
Methods: Over the 5 years from 1996 to 2001, 188 endovascular and direct aortoiliac surgical reconstruction procedures
were performed in 87 women and 101 men with TASC type B and type C iliac lesions and chronic limb ischemia. The
criteria prepared by the AdHoc Committee on Reporting Standards (Society for Vascular Surgery/International Society
for Cardiovascular Surgery (SVS/ISCVS) were followed to define variables. Both univariate analysis (Kaplan-Meier
method) and multivariate analysis (Cox proportional hazards model) were used to determine the association between
variables, cumulative patency rate, limb salvage, and survival.
Results: Indications for revascularization were disabling claudication (73%), limb salvage (25%), and blue toe syndrome
(2%). Patients in the surgery group (n 52) had significantly higher primary patency rates compared with patients in the
stent group (n 136) at univariate analysis (Kaplan-Meier method, log-rank test; P .015). Primary patency rates at 1,
3, and 5 years were 85%, 72%, and 64% after iliac stenting, and 89%, 86%, and 86% after surgical reconstruction,
respectively. Univariate andmultivariate Cox regression analysis enabled identification of poor runoff (ie, runoff score>5
for unilateral procedures or >2.5 for bilateral outflow procedures; relative risk, 2.5; 95% confidence interval [CI],
1.4-4.2; P  .001) as the only independent predictor of decreased primary patency in all patients. However, stratified
analysis including only patients with poor runoff revealed that patients undergoing iliac stenting had significantly lower
primary patency rates compared with those undergoing surgical reconstruction (Kaplan-Meier method, log-rank test;
P  .05). External iliac artery disease and female gender were also identified as independent predictors of decreased
primary stent patency.
Conclusions: Poor infrainguinal runoff is the main risk factor for decreased primary patency after surgical reconstruction
and iliac stenting to treat TASC type B and type C iliac lesions. However, primary patency is less affected by poor runoff
in patients undergoing surgical procedures. The presence of poor runoff, external iliac artery disease, and female gender
are independent predictors of poor outcome after iliac stenting, and therefore these risk factors should determine the need
for surgical reconstruction. (J Vasc Surg 2003;38:272-8.)
Iliac artery angioplasty with stenting has been an option
for treatment of aortoiliac occlusive disease, initially applied
only to focal lesions.1,2 As new types of stents and technical
developments have been introduced, more extensive and
multifocal iliac lesions have been treated with endovascular
procedures.3,4 Scientific and statistical data are lacking,
however, to support treatment of multifocal disease. Aor-
toiliac surgical reconstruction procedures are currently re-
served for more complex anatomic iliac disease or endovas-
cular failures.5,6 The TransAtlantic Inter-Society
Consensus (TASC) working group, a multispecialty effort,
has published a consensus document with recommenda-
tions for management of peripheral arterial disease.7 Of
importance, a newmorphologic stratification of iliac lesions
was introduced to replace outdated classifications that were
not anatomically lesion- specific (Table I). At present the
consensus statements clearly reflect the most current stan-
dard of care.
The TASC classification categorizes iliac artery lesions
according to complexity.7 Type A and type D represent the
two extremes of disease severity. Type A lesions are the
most focal and shortest, whereas type D lesions include the
most diffuse, extensive, and complex lesions; type B and
type C lesions fall between these groups. Endovascular
procedures are considered the treatment of choice for type
A lesions, whereas surgical reconstruction procedures are
the treatment of choice for type D lesions. As the severity of
the lesions increases, the preferred therapeutic option shifts
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from percutaneous endovascular procedures to open surgi-
cal reconstruction. Because of insufficient solid evidence,
the TASC document did not define the best treatment for
TASC type B and type C lesions. Firm recommendations by
the TASC working group were made only for treatment of
type A and type D iliac lesions.
The treatment of choice for TASC type B and type C
iliac lesions is not established. Therefore the decision about
the most appropriate therapeutic option for treatment of
these lesions should take into account risk factors for ad-
verse outcome associated with each procedure. In a recent
study we examined the outcome of iliac angioplasty and
stenting in patients with all types of iliac lesions, and
identified female gender and external iliac artery angio-
plasty as independent predictors of poor primary patency.8
To determine whether these previously identified indepen-
dent predictors also influence the outcome of iliac stenting
and surgical reconstruction in patients with exclusively
TASC type B and type C iliac lesions, only patients with
these lesions were included in the current study.
The purpose of the study was to investigate the influ-
ence of risk factors on outcome in patients undergoing iliac
artery angioplasty and stenting and aortoiliac surgical re-
construction procedures for TASC type B and type C iliac
lesions. Preoperative, procedural, and artery-specific factors
were defined according to the most current recommenda-
tions and standards and were investigated as risk factors for
adverse outcome.7,9,10
METHODS
Between July 1996 and June 2001, 188 patients un-
derwent treatment for iliac artery occlusive disease stratified
as TASC type B and type C iliac lesions at the University of
Tennessee Medical Center at Knoxville. Of these, 178
consecutive iliac angioplasty and stenting procedures (261
stents) were performed in 136 patients, and 60 direct
aortoiliac surgical reconstruction procedures were per-
formed in 52 patients. All patients had evidence of chronic
limb ischemia. Patients with TASC type A and type D iliac
lesions were specifically excluded. Patient demographic
data, procedural and lesion-specific factors, complications,
and outcome variables were defined according to the crite-
ria prepared and revised by the Ad Hoc Committee on
Reporting Standards (Society for Vascular Surgery/Inter-
national Society for Cardiovascular Surgery).11,12 Patients
who underwent extra-anatomic bypass grafting procedures
were also excluded, because these are not direct aortoiliac
surgical reconstruction procedures. Preoperative, intraop-
erative, and follow-up information was available for all
patients and was obtained via office and hospital chart
review, dictated operative records, and telephone conver-
sations with patients, physicians, or family members. The
study protocol was approved by the local institutional re-
view board.
The endovascular procedures were performed in the
operating room by vascular surgeons or in the angiography
suite by interventional radiologists after consultation with
the attending vascular surgeon. Balloon-expandable stents
(Palmaz stent, Cordis J and J, Warren, NJ, and more
recently AVE Bridge stents, Medtronic/AVE, Santa Rosa,
Calif) were used preferentially for more focal lesions, se-
verely calcified lesions, and all lesions adjacent to the aortic
bifurcation. Self-expanding stents (Wallstent, Boston Sci-
entific Corp, Boston, Mass, or AVE Bridge SE stents,
Medtronic/AVE) were usually placed for long-segment
diseased or tortuous iliac arteries and whenever a contralat-
eral approach was used. Stent deployment was deemed
technically successful if there was less than 30% residual
stenosis and if the gradient across the treated lesion was less
than 5 mm Hg. Collagen-impregnated knitted polyester
prostheses (Hemashield; Boston Scientific Corp) were used
for all bilateral aortoiliac surgical reconstructions, whereas
thin-walled expanded polytetrafluoroethylene (Goretex;
W. L. Gore and Associates, Flagstaff, Ariz) was usually used
for unilateral bypass procedures.
Patients were generally seen within 2 weeks after the
procedure. At the discretion of the attending surgeon,
postoperative follow-up, including clinical examination or
serial duplex ultrasound scanning, or both, was conducted
every 3months during the first postoperative year and every
6 months thereafter, although there was no strict postop-
erative surveillance protocol. Arteriography was performed
when noninvasive testing revealed a decrease in ankle-
brachial index (ABI) of 0.15 or more or if peak systolic
velocity was greater than 300 cm/s. Indications for repeat
intervention included stenosis greater than 60% and a gra-
dient across the lesion greater than 10 mm Hg at rest. All
revisions performed on the basis of these criteria or occlu-
sions were considered either stent or graft failure and the
end of primary patency.9
The recently developed TASC classification of disease
severity for iliac lesions was used to define lesion category.7
Runoff was classified from review of both preoperative and
intraoperative arteriograms (Ad Hoc Committee on Re-
porting Standards, SVS/ISCVS).9,10 Runoff was assessed
in the common femoral artery, superficial femoral artery,
and deep femoral artery. Angiographic runoff score was
Table I. TASC morphologic stratification of iliac lesions
Type Definition
A Single stenosis of CIA or EIA 3 cm long (unilateral or
bilateral)
B Single stenosis 3-10 cm long, not extending into CFA
Two stenoses of CIA or EIA not involving CFA 5 cm
Unilateral CIA occlusion
C Bilateral stenoses of CIA and/or EIA not involving CFA
5-10 cm long
Unilateral EIA occlusion not involving CFA
Unilateral EIA stenosis extending into CFA
Bilateral CIA occlusion
D Diffuse stenosis of entire CIA, EIA, and CFA of 10 cm
Unilateral occlusion of CIA and EIA
Bilateral EIA occlusions
Iliac stenosis adjacent to aortic or iliac aneurysms
CIA,Common iliac artery; EIA, external iliac artery;CFA, common femoral
artery.
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further used for subgroup analysis, to categorize scores as
poor runoff (score 5 for unilateral procedures or score
2.5 for bilateral outflow procedures) and good runoff
(score 5 or 2.5 for unilateral or bilateral configuration,
respectively).
Post-hoc power analysis was performed on the data set
to determine the  error and was based on previous stud-
ies.1-8,11-18 Our sample size was large enough to obtain at
least 80% power, with a two-sided type I error rate of 0.05,
to detect differences in 5-year primary patency rates for all
identified independent predictors of primary stent or graft
failure (minimum relative risk [RR], 2).
Clinical characteristics and risk factors were compared
between patients who underwent iliac stenting (stent
group) and those who underwent surgical reconstruction
(surgery group). Univariate analysis of categorical variables
was performed with the Fisher exact test or X2 test with
Yates correction, as indicated (X2 for contingency tables,
two-tailed P value). All analyses were performed according
to the principle of intention-to-treat. Primary patency, limb
salvage, and patient survival were determined with the
Kaplan-Meier method and the log-rank test.18 Cox propor-
tional hazards model was used for multivariate analyses to
assess the influence of various risk factors on primary pa-
tency. Variables with a value of P .25 at univariate analysis
and possible confounding factors were entered into the
regression model and considered significant by forward
stepwise selection at P  .05. For statistical analyses, SPSS
for Windows version 10.0 (SPSS Inc, Chicago, Ill) was
used.19
RESULTS
Median age of the 188 patients was 59 years (range,
36-88 years). The most frequent associated comorbid con-
ditions in the overall group were a history of smoking
(85%), hypertension (71%), coronary artery disease (69%),
hyperlipidemia (56%), and diabetes mellitus (26%). Indica-
tions for revascularization in the stent group were disabling
claudication in 87 patients (64%), limb salvage in 46 pa-
tients (34%), and blue toe syndrome in 3 patients (2%).
Indications for revascularization in the surgery group were
severe claudication in 43 patients (82%), critical ischemia in
8 patients (15%), and blue toe syndrome in 1 patient (2%).
Median follow-up was 27 months (range, 3-64 months).
Median preoperative ABI at rest was 0.49 (range, 0-0.94).
Most endovascular procedures were performed percu-
taneously (68%) with the patient under local anesthesia
(60%). Primary stenting was performed in 73 patients
(41%). Selective stenting was performed because of residual
stenosis or pressure gradient after balloon angioplasty
(40%), dissection after balloon angioplasty (12%), long-
segment occlusion (4%), or eccentric lesion (3%). Stents
were placed in 124 type B lesions (70%) and in 54 type C
lesions (30%). Wallstents were used in 88 procedures
(50%), Palmaz stents in 74 procedures (26%), and a com-
bination of both in 12 procedures (7%). Since October
1999, Medtronic/AVE Bridge SE stents have been used in
18 procedures (10%), and AVE Bridge balloon expandable
stents have been used in 12 procedures (7%). Single stents
were used in 107 lesions (60%), two stents in 59 lesions
(33%), and three stents in 12 lesions (7%). Initial technical
success was obtained in 171 procedures (96%). Forty-three
additional concomitant surgical procedures were per-
formed: 39 infrainguinal bypass graft procedures and 4
femorofemoral bypass graft procedures. Moreover, seven
femoral artery endarterectomies and one profundaplasty
were also performed. There were 23 stent-related vascular
complications: 18 arterial dissections, 4 femoral pseudoan-
eurysms, and 1 vessel perforation. Surgical intervention was
required in 4 dissections, 1 pseudoaneurysm, and the 1
vessel perforation; all were repaired with aortofemoral by-
pass grafting and were considered stent failures. One pa-
tient sustained distal embolization. No stent infections
occurred. Nineteen patients underwent secondary surgical
reconstruction procedures, ie, 12 aortobifemoral, 6 femo-
rofemoral, and 1 iliofemoral bypass graft procedure, at a
median of 9.0 months after the initial iliac angioplasty and
stenting. Systemic complications in the stent group were
limited to two retroperitoneal hematomas that necessitated
transfusion of blood products and one acute myocardial
infarction in a patient who had also undergone concomi-
tant infrainguinal arterial reconstruction.
Most aortoiliac surgical reconstruction procedures
were performed to treat bilateral disease; 24 patients (40%)
underwent aortobifemoral bypass grafting, and 18 patients
(30%) underwent aortobiiliac bypass grafting. To treat
unilateral disease, iliofemoral bypass grafting was per-
formed in 12 patients (20%), aortouniiliac bypass grafting
was performed in 4 patients (7%), and aortofemoral bypass
grafting was performed in 2 patients (3%). Thirteen (22%)
surgical reconstruction procedures were performed be-
cause of failed iliac stenting. Femoral artery endarterec-
tomy, in addition to bypass grafting, was performed in 12
patients, and adjunctive profundaplasty was required in 3
patients. Eight additional concomitant infrainguinal arte-
rial reconstruction procedures were performed in this
group. Surgery-related vascular complications that re-
quired further surgical treatment included superficial fem-
oral artery dissection (1), femoral pseudoaneurysm (1), and
iliofemoral graft infection (1). Systemic complications in
the surgery group that required specific treatment included
perioperative stroke (1), myocardial infarction (1), severe
gastrointestinal bleeding that required transfusion (1),
acute renal insufficiency (1), and pneumonia (1).
Patients in the surgery group had a higher frequency of
disabling claudication as the indication for the procedure,
compared with those in the stent group (80% vs 64%; P 
.027), with no other significant differences noted at univar-
iate analysis with regard to demographic data or clinical
characteristics (Table II). Iliac occlusive disease also tended
to be more extensive and multifocal in the surgery group,
withmore TASC type C lesions (67% vs 30%; P .001) and
more iliac artery occlusions (68% vs 7%; P  .001), com-
pared with the stent group. Runoff scores and number of
concomitant infrainguinal arterial reconstruction proce-
dures were not significantly different between the two
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groups. Moreover, there were no differences between the
groups with respect to tibial artery runoff or patency of the
superficial or deep femoral artery (Table III). More sys-
temic complications occurred in the surgery group (5 vs 3;
P  .02). There was a trend toward more vascular compli-
cations in the stent group, although the difference was not
statistically significant (23 vs 3; P  .14).
Overall, cumulative primary patency rates for all proce-
dures at 1, 3, and 5 years were 86%, 74%, and 69%,
respectively. As expected, patients in the surgery group had
significantly higher primary patency rates compared with
those in the stent group at univariate analysis (Kaplan-
Meier method, log-rank test; P  .015) (Fig 1). Primary
patency rates at 1, 3, and 5 years were 85%, 72%, and 64%
after iliac stenting, and 89%, 86%, and 86% after surgical
reconstruction procedures, respectively. Stratified univari-
ate analyses revealed that in the stent group, primary pa-
tency rates was significantly influenced by poor runoff (P
.001), female gender (P .007), external iliac artery stent-
ing (P  .008), and history of smoking (P  .04). In the
surgery group, risk factors identified at univariate analyses
as significant predictors of primary bypass graft failure
included poor runoff (P  .001), limb-threatening isch-
emia (P  .002), and type of surgical reconstruction, ie,
aortobifemoral and aortobiiliac versus unilateral configura-
tions (P  .01). Thus poor runoff was the only risk factor
identified at univariate analysis to influence significantly
both stent and bypass graft primary patency rates (Fig 2).
However, stratified analyses including only patients with
poor runoff revealed that primary patency rate after iliac
stenting was significantly lower than after surgical proce-
dures (Kaplan-Meier method, log-rank test; P  .05). For
patients with poor runoff, primary patency rates at 1, 3, and
5 years were 74%, 36%, and 36% after iliac stenting, and
80%, 75%, and 68% after aortoiliac surgical reconstruction,
respectively. Primary stent patency rate was not significantly
different in any group for other risk factors analyzed, ie,
diabetes, hypertension, age, hyperlipidemia, type of iliac
lesion, tibial artery runoff, and superficial femoral artery
occlusion. Primary patency rate was not significantly differ-
ent between TASC type B and type C iliac lesions in either
the stent group or the surgery group (P  .7).
Cox regression analysis revealed that poor runoff (RR,
2.5; 95% CI, 1.4-4.2; P  .001) was the only independent
predictor of decreased primary patency for all procedures
when controlling for presence of all other risk factors. In
the iliac stent group, in addition to poor runoff, female
gender and external iliac artery stenting were also indepen-
dent predictors at multivariate analysis (Table IV). For
patients in the surgery group, poor runoff was the only
independent predictor for primary bypass graft failure.
Table II. Clinical characteristics of patient groups
Stent group
(n  136)
Surgery group
(n  52)
Pn % n %
Median age (y) 61 57 NS
Female sex 58 43 27 52 NS
Comorbidity
Diabetes mellitus 37 27 11 21 NS
Hypertension 98 72 32 62 NS
Smoking history 115 85 43 83 NS
Coronary artery
disease
94 69 31 60 NS
Hyperlipidemia 78 55 28 55 NS
Renal insufficiency*
(Cr  1.6)
16 12 5 10 NS
Indication
Claudication 87 64 43 83 .014†
Rest pain 24 18 4 8 NS
Tissue loss 22 16 4 8 NS
Blue toe syndrome 3 2 1 2 NS
NS, Not significant.
*Creatinine 1.6.
†X2 test.
Table III. Distribution, characteristics, and procedural
factors of 238 endovascular and surgical procedures for
TASC type B and type C iliac lesions
Stent group
(n  178)
Surgery group
(n  60)
Pn % n %
Iliac disease
Stenosis 165 93 19 32 .001*
Occlusion 13 7 41 68 .001*
TASC stratification of iliac
lesions
Type B 124 70 20 33 .001*
Type C 54 30 40 67 .001*
EIA involvement 69 39 22 37 NS
Poor runoff (score 5) 48 27 20 33 NS
Ipsilateral SFA occlusion 31 17 9 15 NS
EIA,External iliac artery; SFA, superficial femoral artery;NS, not significant.
*X2 test.
Fig 1. Surgery group demonstrated significantly higher primary
patency rate compared with stent group at univariate analysis
(Kaplan-Meier method, log-rank test; P  .015).
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For all patients, limb salvage at 1, 3, and 5 years was
98%, 96%, and 95%, respectively. Cox regression multivar-
iate analysis revealed that poor runoff (RR, 5.0; 95% CI,
1.3-18.9; P  .02) was an independent predictor of re-
duced limb salvage for all procedures, although at stratified
analyses the influence of this risk factor after surgical recon-
struction was less significant (P  .08). One operative
death (within 30 days) due to myocardial infarction oc-
curred in a patient who had undergone iliac stenting com-
bined with infrainguinal arterial reconstruction. No periop-
erative deaths occurred in the surgery group. Overall,
patient survival was 95% at 1 year, 81% at 3 years, and 78%
at 5 years. Cumulative patient survival was not significantly
different between the two groups (Kaplan-Meier method,
log-rank test; P .37). Smoking history (RR, 3.9; 95% CI,
1.9-8.4; P  .001) and hyperlipidemia (RR, 2.7; 95% CI,
1.3-5.7; P .007) were the only independent predictors of
decreased long-term survival at multivariate analyses.
DISCUSSION
Many techniques for revascularization in aortoiliac oc-
clusive disease are available, including surgical and endo-
vascular procedures. However, only a few observational
studies have directly compared these two types of recon-
struction procedures.13,20,21 In recent years the advent of
new technology and new types of stents has extended the
use of endovascular procedures to more extensive and
multilevel aortoiliac occlusive disease. The TASC docu-
ment, the most recent comprehensive review of manage-
ment of peripheral arterial disease, left unresolved critical
issues such as the best treatment for moderately severe iliac
occlusive disease, ie, TASC type B and type C iliac lesions.7
Furthermore, a clear dissenting opinion was expressed by
the Cardiovascular and Interventional Radiology Society of
Europe (CIRSE), which considered that, because of recent
technical developments, type B and type C lesions could
also be treated with endovascular procedures with accept-
able technical success. However, CIRSE admitted that,
although in clinical practice endovascular techniques are
commonly used for treatment of these lesions, currently no
scientific evidence exists to support such an approach. Only
randomized clinical trials comparing iliac stenting and di-
rect aortoiliac surgical reconstruction procedures could
indicate the best treatment option for these lesions, but
thus far no controlled trials have been conducted. More-
over, only a few studies have stratified procedural features
according to TASC lesion types. In this regard, we believe
that stratified analyses are necessary to define specific risk
factors for different subgroups of patients, as emphasized
by the Ad Hoc Committee on Reporting Standards (SVS/
ISCVS).9 Therefore, and as a preliminary step, our current
experience with both surgical and endovascular procedures
for treatment of TASC type B and type C iliac lesions was
analyzed in the current observational study.
Analysis of our data indicates that poor runoff is the
most important independent predictor of primary failure
after both surgical and endovascular procedures used to
treat TASC type B and type C iliac lesions. Stratified
analyses also revealed that in patients with poor runoff, iliac
stenting yielded significantly inferior primary patency rates
compared with surgical reconstruction. Therefore, in le-
sions with equivalent poor runoff, surgical procedures offer
the best results. In previous studies inadequate infraingui-
nal runoff was identified as an important risk factor for
long-term aortofemoral bypass graft failure and for iliac
stent failure.2,5,6,8,12-15 However, in most studies different
schemes for grading runoff have been used, rather than the
angiographic runoff score proposed by the Ad Hoc Com-
mittee on Reporting standards (SVS/ISCVS). For exam-
ple, Ballard et al13 examined the treatment of severe aor-
toiliac occlusive lesions, ie, TASC type D iliac lesions, and
found that ipsilateral superficial femoral artery occlusion
was an independent predictor of both bypass graft failure
and stent failure. Conversely, tibial artery runoff did not
influence primary patency. The angiographic runoff score
was not used. In our study, ipsilateral superficial femoral
artery occlusion did not predict either bypass graft failure or
stent failure, probably because only less severe iliac lesions
were included. In this regard, in our opinion angiographic
runoff score is the most comprehensive grading scheme
available. Of importance, all levels of distal disease are
considered, including both the degree of occlusion and
stenosis, and the relative contribution of each outflow
vessel.9 Because only bypass grafts with the same level of
distal anastomosis can be compared, in our study the an-
giographic runoff score was further used for subgroup
analysis, to categorize scores as poor runoff (score 5 for
unilateral procedures or 2.5 for bilateral outflow proce-
dures) and good runoff. Such stratification has been used
before, and enabled us to compare all procedures.8,22
There are several potential limitations to our study,
including lack of randomization, and potential bias and
confounding effects associated with any observational
Fig 2. Poor runoff was the only risk factor identified at univariate
analysis that affected significantly both stent and bypass graft
primary patency rates. (Kaplan-Meier method, log-rank test; P 
.001).
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study. For example, there was a higher proportion of
women in the surgery group compared with the stent
group, although this difference was not statistically signifi-
cant (43% vs 53%, respectively; P .22). This sex distribu-
tion may represent a selection bias based on our previous
experience with iliac stenting, which consistently showed a
worse outcome in women. Such bias, however, should not
affect the analysis of variables other than gender. Inasmuch
as a randomized controlled trial of surgical treatment of
iliac occlusive disease has not been performed and is un-
likely to be conducted in the future, we must rely on data
from observational studies to draw conclusions and make
recommendations.
In our current practice, TASC type B and type C lesions
are more frequently treated with endovascular procedures,
as in this series. Although the initial technical success is
comparable between endovascular and surgical reconstruc-
tion procedures, long-term results were significantly supe-
rior in the surgery group. Thus far, in addition to patient
preference, the main risk factor considered in our practice
in selecting among different therapeutic options has been
presence of iliac stenosis versus occlusion. Surgical manage-
ment has been used more liberally in patients with iliac
occlusions, eg, TASC lesion subtypes B-4, C-6, and C-8.
However, identification of independent predictors for pri-
mary stent failure, in our opinion, would clearly indicate
which patients would be better served with surgical proce-
dures rather than iliac stenting. Furthermore, sinceminimal
morbidity and no perioperative mortality were attained in
our carefully selected surgery group, such approach is
clearly justified. As in our previous study, in which all iliac
lesion types were included, female sex and external iliac
artery stenting were also independent predictors of primary
failure for TASC type B and type C iliac lesions in the stent
group. Since no other independent predictors, other than
poor runoff, were identified in the surgery group, presence
of these risk factors should determine need for surgical
reconstruction, to obtain the best outcome with the initial
procedure.
In conclusion, poor runoff is the main risk factor for
reduced primary patency after surgical reconstruction and
iliac stenting used to treat TASC type B and type C iliac
lesions. However, primary patency rate was less affected by
poor runoff in patients undergoing surgical procedures.
Female sex and external iliac artery occlusive disease are also
independent predictors of primary failure after iliac stent-
ing, and therefore the presence of these risk factors should
determine need for surgical reconstruction.
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